Cardlytics (CDLX) Reports Q3 Loss of $0.15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Cardlytics (CDLX) PT Lowered to $26 at KeyBanc Following 3Q
November 14, 2018 8:22 AM ESTKeyBanc analyst Andy Hargreaves lowered the price target on Cardlytics (NASDAQ: CDLX) to $26.00 (from $28.00) while maintaining a Overweight rating following the company's 3Q. Cardlytics reported mixed 3Q18 results as revenue missed due to advertiser churn, but cost management preserved upside in profitability... More
